BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24059102)

  • 1. [Effect of RAAS antagonist on the expression of gap junction cx43 in myocardium of spontaneously hypertensive rat].
    Tan LL; Li L; Liu LM; Zhao HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):531-5, 549. PubMed ID: 24059102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
    Susic D; Varagic J; Frohlich ED
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1177-81. PubMed ID: 20118410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
    Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
    Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive rats.
    Zhao LL; Chen HJ; Chen JZ; Yu M; Ni YL; Zhang WF
    J Zhejiang Univ Sci B; 2008 Jun; 9(6):448-54. PubMed ID: 18543397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model.
    Stein M; Boulaksil M; Jansen JA; Herold E; Noorman M; Joles JA; van Veen TA; Houtman MJ; Engelen MA; Hauer RN; de Bakker JM; van Rijen HV
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H310-21. PubMed ID: 20435847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
    Dupuis F; Vincent JM; Limiñana P; Chillon JM; Capdeville-Atkinson C; Atkinson J
    J Hypertens; 2010 Jul; 28(7):1566-73. PubMed ID: 20589978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
    Olverling A; Huang Z; Nyström T; Sjöholm Å
    Clin Sci (Lond); 2013 Nov; 125(9):433-8. PubMed ID: 23713675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Ramipril on the expression of connexin 43 in cerebral arteries of spontaneously hypertensive rats].
    Tian T; Tan CY; Jia QH; Cong WW; Tian JJ; Ma KT; Li L; Si JQ
    Sheng Li Xue Bao; 2019 Jun; 71(3):395-404. PubMed ID: 31218330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensin-converting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats.
    Dupuis F; Atkinson J; Limiñana P; Chillon JM
    J Hypertens; 2005 May; 23(5):1061-6. PubMed ID: 15834293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
    Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
    J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure.
    Muñoz-Pacheco P; Ortega-Hernández A; Caro-Vadillo A; Casanueva-Eliceiry S; Aragoncillo P; Egido J; Fernández-Cruz A; Gómez-Garre D
    J Hypertens; 2013 Nov; 31(11):2309-18; discussion 2319. PubMed ID: 24077250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
    Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?
    Tylicki L; Lizakowski S; Rutkowski P; Renke M; Sulikowska B; Heleniak Z; Donderski R; Bednarski R; Przybylska M; Manitius J; Rutkowski B
    Kidney Blood Press Res; 2012; 36(1):335-43. PubMed ID: 23235363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
    Miesel A; Müller-Fielitz H; Jöhren O; Vogt FM; Raasch W
    Br J Pharmacol; 2012 Apr; 165(8):2721-35. PubMed ID: 22014027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
    J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
    Sanchez RA; Masnatta LD; Pesiney C; Fischer P; Ramirez AJ
    J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Telmisartan reduces retina vessel endothelial cell apoptosis via upregulating retinal ACE2-Ang-(1-7)-Mas axis in spontaneous hypertensive rats].
    Lin Z; Ni Y; Hou L; Song L; Wu Y; Hu H; Zhang J; Yang D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Jul; 43(7):625-30. PubMed ID: 26420325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.